Download PDF
Am J Perinatol 2000; Volume 17(Number 05): 237-242
DOI: 10.1055/s-2000-10004
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

EFFECT OF ANTIBIOTIC THERAPY IN PRETERM PREMATURE RUPTURE OF THE MEMBRANES ON NEONATAL MORTALITY AND MORBIDITY

Jacob Bar1 , Ayala Maayan-Metsger2 , Moshe Hod1 , Zion Ben Rafael1 , Raoul Orvieto1 , Yosef Shalev1 , Lea Sirota2
  • 1Department of Obstetrics & Gynecology, Rabin Medical Center, Beilinson Campus, Petah Tiqva
  • 2Department of Neonatology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Isarel
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Also available at
    Permissions and Reprints

ABSTRACT

The objective of this study was to evaluate the effect of prophylactic antibiotic treatment on prenatal and neonatal outcome after preterm premature rupture of the membranes (P-PROM). The study population consisted of 172 pregnant women admitted to the Rabin Medical Center in Israel with P-PROM at 23-34 gestational weeks. The patients were divided into two groups by mode of expectant management-prophylactic ampicillin and erythromycin (study group, n = 121) or observation only (control group, n = 51) and compared for neonatal outcome. There were no significant differences between the groups in age, gravidity, parity, or gestational age at admission. Significantly more women in the study group had an interval of more than 24 hours from onset of P-PROM to delivery (98 women, 81%) than the control group (32 women, 63%) (p = 0.001). The neonatal mortality rate was significantly lower in the study group (6.6%) than the control group (17.6%) (p = 0.03). The lower neonatal mortality rate associated with prophylactic antibiotic treatment in P-PROM has important clinical implications for the effectiveness of this type of management.

KEYWORD

P-PROM - antibiotics - prophylaxis - neonatal mortality

REFERENCES

  • 1 Romero R, Yoon B H, Mazor M. A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, interleukin-6, and Gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes.  Am J Obstet Gynecol . 1993;  169 839-851
    CrossrefPubMedGoogle Scholar
  • 2 Mueller-Heubach E, Rubinstein D N, Schwarz S S. Histologic chorioamnionitis and preterm delivery in different patients populations.  Obstet Gynecol . 1990;  75 622-626
    PubMedGoogle Scholar
  • 3 Garite T J, Freeman R K. Chorioamnionitis in the preterm gestation.  Obstet Gynecol . 1982;  59 539-545
    PubMedGoogle Scholar
  • 4 McDonald H M, O'Loughlin J A, Jolley P, Vigneswaran R, McDonald P J. Prenatal microbiological risk factors associated with preterm birth.  Br J Obstet Gynaecol . 1992;  99 190-196
    CrossrefPubMedGoogle Scholar
  • 5 Minkoff H, Grunebaum A N, Schwarz R H. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy.  Am J Obstet Gynecol . 1984;  150 965-972
    PubMedGoogle Scholar
  • 6 Morlaes W J, Angel J L, O'Brien W F, Knuppel R A. Use of ampicillin and corticosteroids in premature rupture of membranes: a randomized study.  Obstet Gynecol . 1989;  73 721-726
    PubMedGoogle Scholar
  • 7 Lockwood C J, Costigan K, Ghidini A. Double-blind, placebo-controlled trial of piperacillin prophylaxis in preterm membrane rupture.  Am J Obstet Gynecol . 1993;  169 970-976
    CrossrefPubMedGoogle Scholar
  • 8 Mercer B M, Moretti M L, Prevost R R, Sibai B M. Erythromycin therapy in preterm premature rupture of the membranes: a prospective, randomized trial of 220 patients.  Am J Obstet Gynecol . 1992;  166 794-802
    PubMedGoogle Scholar
  • 9 Mercer B M, Arheart K L. Antimicrobial therapy in expectant management of preterm premature rupture of the membranes.  Lancet . 1995;  346 1271-1279
    CrossrefPubMedGoogle Scholar
  • 10 Egarter C, Leitich H, Karas H. Antibiotic treatment in preterm premature rupture of membranes and neonatal morbidity: a meta-analysis.  Am J Obstet Gynecol . 1996;  174 589-597
    PubMedGoogle Scholar
  • 11 Kenyon S, Boulvein M. Antibiotics for preterm premature rupture of membranes.  Cochrane Libr . 1999;  4 1-11
    PubMedGoogle Scholar
  • 12 Locksmith G J. Antibiotic therapy in preterm premature rupture of membranes.  Clin Obstet Gynecol . 1998;  41 864-869
    CrossrefPubMedGoogle Scholar
  • 13 Mercer B M. Management of preterm premature rupture of the membranes.  Clin Obstet Gynecol . 1998;  41 870-882
    CrossrefPubMedGoogle Scholar
  • 14 Mercer B M, Miodovnik M, Thurnau G R. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes.  JAMA . 1997;  278 989-995
    CrossrefPubMedGoogle Scholar
  • 15 Papile L A, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm.  J Pediatr . 1978;  92 529-534
    CrossrefPubMedGoogle Scholar
  • 16 Ernest J M. Neonatal consequences of preterm PROM.  Clin Obstet Gynecol . 1998;  41 827-831
    CrossrefPubMedGoogle Scholar
  • 17 Ananth C V, Guise J M, Thorp Jr M J. Utility of antibiotic therapy in preterm premature rupture of membranes: a meta-analysis.  Obstet Gynecol Surv . 1996;  51 324-3281
    CrossrefPubMedGoogle Scholar